{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:00:08Z","timestamp":1780412408584,"version":"3.54.1"},"reference-count":25,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2009,5,13]],"date-time":"2009-05-13T00:00:00Z","timestamp":1242172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2009,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:bold>Background: <\/jats:bold> Anti\u2010neutrophil cytoplasm antibodies (ANCA) have been detected in serum from patients affected by autoimmune CLD, and to a lesser extent, in serum of patients affected by non autoimmune CLD. The clinical significance of ANCA in these disorders is still unclear.<\/jats:p><jats:p><jats:bold>Aims: <\/jats:bold> To explore the clinical and diagnostic significance of ANCA in CLD.<\/jats:p><jats:p><jats:bold>Materials and methods: <\/jats:bold> Forty\u2010five sera from patients affected by HCV\u2010 and HBV\u2010related CLD (group 1), 29 sera from patients affected by alcohol\u2010related CLD (Group 2) and 33 sera from patients affected by autoimmune\u2010related liver diseases including chronic autoimmune hepatitis (AIH), primary sclerosing cholangitis (PSC) and primary biliary cirrhosis (PBC), (Group 3) have been studied by using IIF and ELISA.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> A low correspondence between the ANCA positivity obtained by IFI and ELISA was observed. The positivity for at least one ANCA antigen was observed in 60,0% of Group 1, in 44,8% of Group 2 and in 72,7% of Group 3. The relation between the aetiology of the disease and the number of positive ANCA tests in ELISA was not significant. The relation between the MELD score and the number of ANCA positivity in patients with cirrhosis in the autoimmune\u2010related CLD and in the viral\u2010related CLD has been investigated. In both Groups a significant worsening of MELD at increasing number of ANCA positivity was found. Moreover in patients without cirrhosis in Group 3 an increase in the ALT and AST activity in patients with at least one ANCA positivity was observed.<\/jats:p><jats:p><jats:bold>Conclusions: <\/jats:bold> These data suggest that the finding of ANCA by ELISA is common not only in autoimmune CLD but, also in viral\u2010related CLD. Patients with autoimmune\u2010related CLD express more frequently a multiple antigen reactivity as compared to those with viral\u2010related CLD. The positivity for ANCA might have a prognostic value in patients with viral\u2010related as well as autoimmune\u2010related cirrhosis since it is associated with worse MELD score.<\/jats:p>","DOI":"10.1111\/j.1478-3231.2009.01989.x","type":"journal-article","created":{"date-parts":[[2009,5,13]],"date-time":"2009-05-13T11:56:56Z","timestamp":1242215816000},"page":"865-870","source":"Crossref","is-referenced-by-count":13,"title":["What is behind the presence of anti\u2010neutrophil cytoplasmatic antibodies in chronic liver disease?"],"prefix":"10.1111","volume":"29","author":[{"given":"De Riva","family":"Valentina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celadin","family":"Marilena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pittoni","family":"Marina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Plebani","family":"Mario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,6,5]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"425","article-title":"Autoantibodies against neutrophils and monocytes","volume":"1","author":"Van Der Woude FJ","year":"1985","journal-title":"tool for diagnosis and marker of disease activity in Wegener's granulomatosis"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/111.4.507"},{"key":"e_1_2_5_4_2","first-page":"1","article-title":"Anti\u2010neutrophil cytoplasmic antibodies","volume":"46","author":"Kallenberg CGM","year":"1994","journal-title":"current diagnostic and pathophysiological potential"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2007.11.005"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2001.01649.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1385\/CRIAI:28:2:115"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510250510"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80241-X"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80508-2"},{"key":"e_1_2_5_12_2","first-page":"1","article-title":"Autoantibodies and autoantigens in autoimmune hepatitis","volume":"1","author":"Zachou K","year":"2004","journal-title":"important tools in clinical practice and to study pathogenesis of the disease"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840170310"},{"key":"e_1_2_5_14_2","first-page":"437","article-title":"Anti\u2010neutrophil cytoplasmic antibodies in patients with chronic liver diseases","volume":"15","author":"Lindgren S","year":"2000","journal-title":"prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease"},{"key":"e_1_2_5_15_2","first-page":"581","article-title":"Antineutrophil cytoplasmic antibodies in chronic liver diseases","volume":"24","author":"Bansi D","year":"1996","journal-title":"prevalence, titre, specificity and IgG subclass"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.22172"},{"key":"e_1_2_5_17_2","first-page":"998","article-title":"Meeting report","volume":"18","author":"Johnson PJ","year":"1993","journal-title":"international autoimmune hepatitis group"},{"key":"e_1_2_5_18_2","first-page":"929","article-title":"International autoimmune hepatitis group report","volume":"31","author":"Alvarez F","year":"1999","journal-title":"review of criteria for diagnosis of autoimmune hepatitis"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra043898"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2007.09.009"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1997.tb00509.x"},{"key":"e_1_2_5_22_2","first-page":"101","article-title":"Anti\u2010neutrophil cytoplasmic antibodies tests","volume":"40","author":"Wiik A.","year":"2001","journal-title":"which tests should be used in practice?"},{"key":"e_1_2_5_23_2","first-page":"101","article-title":"Autoantibodies in chronic liver disease","volume":"12","author":"Ghonaim M","year":"2005","journal-title":"Egypt J Immunol"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01827.x"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.34.1.56"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00062752-199502010-00013"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2009.01989.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2009.01989.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T18:19:54Z","timestamp":1697134794000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2009.01989.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,5]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["10.1111\/j.1478-3231.2009.01989.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2009.01989.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,5]]}}}